Uterine Fibroids: The Silent Epidemic Behind Porsha Williams’s Emergency Hysterectomy

When a surgeon opens an abdomen expecting a routine procedure and counts twenty-one separate tumors growing inside a single uterus, the number stops being a medical detail. It becomes an indictment of how quietly this disease operates. That is exactly what television personality Porsha Williams described when she revealed she underwent an emergency partial hysterectomy after doctors discovered 21 uterine fibroids — a disclosure that rippled far beyond celebrity news because it mirrored the private reality of millions of women who have been told their crushing pelvic pressure, exhausting periods, and constant urinary urgency were simply “normal.”

They are not normal. They are the signature of the most common tumor in the female reproductive tract, a condition that will touch up to eight in ten women by midlife and yet remains chronically under-discussed, under-screened, and under-treated until it forces an emergency. As a strategist focused on metabolic and regenerative biology, I look at fibroids the same way I look at any chronic disease: not as random bad luck, but as the downstream expression of a biological terrain. Hormones are the fuel, but metabolism, inflammation, gut ecology, and environmental chemistry build the engine.

This is a deep, systems-level breakdown of what uterine fibroids actually are, why they grow so aggressively in some bodies and not others, why the burden falls so unfairly on Black women, and — most importantly — the levers you can pull today to engineer a terrain where fibroids struggle to take root.

The Story: Twenty-One Fibroids and an Emergency Decision

As reported in mainstream coverage of her disclosure, Williams revealed that what began as worsening pelvic symptoms culminated in an emergency partial hysterectomy, during which surgeons identified 21 distinct fibroids. She has previously spoken publicly about her fibroid diagnosis and the complications it introduced into her fertility journey, including the emotional toll of navigating pregnancy planning around a uterus crowded with tumors.

Strip away the celebrity framing and the clinical picture is familiar to any gynecologic surgeon. Fibroids rarely announce themselves with a single dramatic event. They accumulate. A woman notices her periods getting heavier, then longer, then clotting. She feels fullness she attributes to bloating or weight gain. She wakes at night to urinate. She cancels workouts because of pelvic dragging. Each symptom is individually tolerable and easily dismissed, so the collective pattern goes uninvestigated for years — while the tumors, fed by estrogen and progesterone every single cycle, continue to expand.

By the time bleeding becomes hemorrhagic or mass effect compresses the bladder, bowel, or ureters, the window for conservative, fertility-sparing options has often closed. That is how a benign condition ends in an emergency operating room. The tragedy is not the surgery; it is the decade of silence that made the surgery urgent.

What Are Uterine Fibroids? The Biology of Leiomyomas

Uterine fibroids — clinically termed leiomyomas or myomas — are benign monoclonal tumors arising from the smooth muscle cells of the uterine wall. They are not cancer, and the vast majority never become cancer. But “benign” is a pathological label, not a description of impact. A benign tumor can still bleed you into anemia, compress your organs, distort your uterine cavity, and dismantle your quality of life.

Location Dictates Destiny

Fibroids are classified by where they grow, and location determines both symptoms and surgical strategy:

• Submucosal: Project into the uterine cavity. Even small ones cause devastating heavy bleeding and implantation failure.
• Intramural: Embedded within the muscular wall. The most common type; drives bulk symptoms and uterine enlargement.
• Subserosal: Grow outward toward the pelvic cavity. Can reach enormous sizes before causing symptoms, often presenting as pressure or visible abdominal distension.
• Pedunculated: Hang from a stalk. Prone to torsion, which causes acute, surgical-grade pain.

The Hormonal Growth Engine

Fibroids are profoundly hormone-dependent. They express estrogen and progesterone receptors at densities far exceeding normal myometrium, and both steroids drive their proliferation, with progesterone acting as the dominant mitogenic signal. This is why fibroids almost never appear before menarche, accelerate through the reproductive years, swell during pregnancy, and typically regress after menopause when ovarian steroid production collapses. It is also why so many medical therapies target the hormonal axis rather than the tumor directly.

The Genetic Seed

Hormones are the fuel, but a genetic lesion lights the match. The majority of fibroids harbor somatic mutations in the MED12 gene, a component of the transcriptional machinery, while a smaller subset is driven by HMGA2 rearrangements. Each fibroid is clonal — descended from a single mutated smooth muscle cell that escaped normal growth control. Understanding this changes the mental model: fibroids are not diffuse uterine disease, they are discrete neoplastic colonies expanding within a permissive hormonal and metabolic environment.

Why Fibroids Grow: The Metabolic and Inflammatory Terrain

If fibroids were purely genetic and hormonal, we would see uniform prevalence across populations with similar ovaries. We do not. Prevalence, size, number, and recurrence vary dramatically — and that variation tracks closely with metabolic health, body composition, gut ecology, and environmental exposure. This is the terrain model, and it is where you have leverage.

Insulin Resistance and the Fat-Estrogen Axis

Adipose tissue is not inert storage; it is an active endocrine organ. Visceral fat expresses aromatase, the enzyme that converts circulating androgens into estrogens, meaning excess body fat manufactures its own estrogen supply independent of the ovaries. Simultaneously, hyperinsulinemia suppresses hepatic production of sex hormone-binding globulin (SHBG), raising the fraction of free, biologically active estrogen available to feed tumor growth. Insulin-like growth factor-1 (IGF-1), elevated in insulin-resistant states, adds a direct proliferative signal to smooth muscle cells.

The clinical implication is blunt: glycemic chaos is fibroid fertilizer. If your glucose curve spikes and crashes all day, you are running a hormonal environment that favors tumor expansion. Flatten that curve using the protocols in our Glycemic Variability masterclass, and audit your true visceral burden with our Advanced BMI Calculator and Body Fat Calculator — standard scales will not show you the aromatase factory hiding around your organs.

The Estrobolome: Your Gut’s Role in Estrogen Dominance

Estrogen is metabolized in the liver, conjugated for excretion into bile and urine — and then, in a healthy gut, largely eliminated. But specific gut bacteria express beta-glucuronidase, an enzyme that deconjugates estrogen and sends it back through the intestinal wall into circulation. The collective of these bacteria is called the estrobolome, and its composition directly sets your circulating estrogen load.

A dysbiotic gut — shaped by emulsifiers, low fiber, antibiotics, and ultra-processed diets — skews toward high beta-glucuronidase activity, recycling estrogen the body was trying to discard. This is a genuine, modifiable mechanism of estrogen dominance. Rebuilding keystone species and feeding them fermentable fiber is not a wellness luxury here; it is hormonal engineering. Our Next-Gen Probiotics protocol maps exactly how.

Endocrine Disruptors and the Environmental Load

Xenoestrogens — phthalates in plastics and fragrances, bisphenols in liners and receipts, certain parabens and PFAS compounds — mimic or interfere with estrogen signaling and have been associated with fibroid risk in epidemiological studies. You cannot eliminate exposure, but you can materially reduce it: filter your water, store food in glass, discard fragranced personal care products, and never heat food in plastic. Our investigation into the silent toxins in everyday tap water is a practical starting point for the water piece.

The Vitamin D Deficit

A consistent inverse relationship appears across populations: lower serum vitamin D correlates with higher fibroid prevalence and growth. Vitamin D regulates cell differentiation and suppresses proliferative signaling in leiomyoma cells. Given the high prevalence of insufficiency — especially in darker-skinned individuals living at higher latitudes — testing and repleting to a robust serum range is one of the cheapest, highest-yield interventions on this list.

The Disparity: Why Black Women Carry a Heavier Burden

Any honest discussion of uterine fibroids must confront the epidemiology: Black women develop fibroids at two to three times the rate of white women, experience them at younger ages, grow larger and more numerous tumors, and face substantially higher rates of hemorrhage, anemia, and hysterectomy. Porsha Williams’s story — 21 fibroids, emergency surgery — sits inside a statistical pattern, not outside it.

The drivers are multifactorial and only partly understood: higher prevalence of vitamin D deficiency, greater cumulative allostatic stress load with documented cortisol-dysregulation effects on steroid metabolism, differential exposure to endocrine-disrupting chemicals, genetic susceptibility loci, and — critically — systemic delays in diagnosis and treatment. Heavy bleeding in Black women is more likely to be normalized, dismissed, or managed with repeated emergency visits rather than early imaging and definitive planning.

This is where advocacy becomes clinical intervention. If you are a Black woman with worsening menstrual bleeding or pelvic pressure, you are statistically entitled to earlier, more aggressive workup — not watchful waiting until you are anemic. Request pelvic imaging. Request a ferritin and complete blood count. Bring a written symptom diary. The data says your symptoms are more likely to be minimized; your preparation is what counters it.

Symptoms: The Warning Signs Written Off as “Normal”

Fibroids are masterfully silent early and brutally loud late. The gap between those phases is your diagnostic window. Watch for:

• Menorrhagia: Periods lasting longer than seven days, soaking through protection hourly, or passing clots larger than a quarter.
• Anemia signatures: Fatigue, breathlessness on stairs, pale conjunctiva, brittle nails, restless legs — the downstream face of chronic blood loss.
• Bulk symptoms: Pelvic pressure or fullness, clothing fitting differently at the lower abdomen, visible distension mistaken for weight gain.
• Compression symptoms: Urinary frequency or retention, constipation, rectal pressure, hydronephrosis in advanced cases.
• Pain: Dull pelvic ache, dyspareunia, or acute pain from torsion or degeneration.
• Reproductive impact: Infertility, recurrent miscarriage, or obstetric complications depending on cavity distortion.

Heavy periods are not a personality trait or a family tradition. They are a measurable clinical sign with a measurable cause.

Diagnosis and Treatment: From Surveillance to Surgery

Diagnosis is straightforward when it is actually pursued: pelvic examination, transvaginal ultrasound as first-line imaging, saline infusion sonohysterography for cavity assessment, and MRI for surgical mapping. MRI in particular has transformed preoperative planning, allowing precise counting and mapping of fibroids — the step that distinguishes a planned myomectomy from an intraoperative surprise.

Medical and Minimally Invasive Options

Current clinical guidance from the American College of Obstetricians and Gynecologists frames management as a spectrum matched to symptoms, fertility goals, and anatomy:

When Hysterectomy Becomes the Answer

A hysterectomy is the only definitive cure, and in emergencies — uncontrolled hemorrhage, severe mass effect, hemodynamic instability — it is the correct and lifesaking choice. A partial (supracervical) hysterectomy removes the uterine body while preserving the cervix; a total hysterectomy removes both. Crucially, unless the ovaries are also removed, neither induces surgical menopause, because ovarian hormone production continues. Patients often fear instant menopause after hysterectomy; in most partial and total procedures with ovarian conservation, that fear is unfounded.

What deserves sharper conversation is the upstream failure: how many of these emergencies were preventable with earlier imaging, earlier medical suppression, and earlier elective myomectomy? Definitive surgery performed electively, on your schedule, with full counseling, is a fundamentally different experience — and outcome — than definitive surgery performed at 2 a.m. against a hemorrhaging clock.

The Defense Protocol: Engineering a Fibroid-Resistant Terrain

You cannot edit your MED12 status. You can absolutely edit the terrain those mutations exploit. This is the protocol I walk clients through, ordered by leverage.

1. Metabolic Control and Body Composition

Reduce the aromatase factory. Prioritize visceral fat loss through resistance training, protein-anchored meals, and glycemic control — not crash dieting, which raises cortisol and destabilizes hormones. Calculate your true energy expenditure with our TDEE Calculator so your deficit is sustainable, and keep lean mass as your glucose sink. Every percentage point of visceral fat removed is estrogen you are no longer manufacturing.

2. Estrogen Metabolism Support

• Cruciferous vegetables daily: Broccoli sprouts, kale, and cabbage supply indole-3-carbinol and DIM, which steer estrogen metabolism toward safer hydroxylation pathways.
• Fiber at 30–40 grams daily: Binds conjugated estrogens in the gut and accelerates fecal elimination, directly countering estrobolome recycling.
• Ground flaxseed: Modulates estrogen receptor signaling and supports favorable metabolism; one to two tablespoons daily.
• Alcohol reduction: Alcohol raises circulating estrogen and impairs hepatic estrogen clearance; this is one of the strongest modifiable associations in the literature.
• Green tea catechins: Epigallocatechin gallate (EGCG) has demonstrated anti-proliferative effects on leiomyoma cells in clinical investigation, making concentrated green tea extract a rational adjunct worth discussing with your clinician.

3. Vitamin D Repletion and Sunlight

Test 25(OH)D. Replete to a robust serum range under medical supervision, and pair supplementation with regular midday sun exposure. This is inexpensive, safe, and mechanistically grounded.

4. Gut Repair and the Estrobolome

Feed the bacteria that keep beta-glucuronidase low: diverse plants, resistant starch, fermented foods. Consider calcium-D-glucarate, which supports the glucuronidation pathway and inhibits bacterial deconjugation. Our Next-Gen Probiotics protocol details the keystone species worth cultivating.

5. Environmental Load Reduction

Filter water, swap plastics for glass, audit personal care products for phthalates and parabens, and avoid heating food in plastic. Chronic low-dose xenoestrogen exposure is a terrain variable you control more than you think.

6. Surveillance and Self-Advocacy

If you have heavy periods, pelvic pressure, a family history of fibroids, or you are a Black woman with any menstrual change, request imaging before you are anemic. Track cycle length, flow volume, and clot size in a written log. Bring ferritin, CBC, and vitamin D labs to every annual visit. Early detection converts emergencies into electives.

💡 Action Step: Fibroid risk is tightly coupled to visceral adiposity and insulin resistance — two metrics a bathroom scale cannot see. Establish your true baseline with our Advanced BMI Calculator, confirm your adipose burden with our Body Fat Calculator, and build your recomposition plan around our TDEE Calculator. Data first, protocol second.

Final Thoughts

Porsha Williams’s disclosure did something more valuable than generate headlines: it made a hidden epidemic visible. Twenty-one fibroids do not appear overnight, and they do not appear without a terrain that permitted them. Hormones sign the permit, but metabolism, inflammation, gut ecology, environmental chemistry, and — unfairly — systemic delays in care pour the foundation.

That framing is empowering, because terrain is modifiable. You can flatten your glucose curve, rebuild your estrobolome, replete your vitamin D, cut your xenoestrogen load, and demand early imaging instead of late apologies. And if surgery is ultimately your path — partial, total, elective, or emergency — it is a valid, definitive choice, not a failure. The goal was never to avoid medicine. The goal was to arrive at medicine early, informed, and in control.

Your uterus keeps score in silence. Start listening before it has to shout.

Frequently Asked Questions (FAQ)

⚕️ Editorial & Medical Disclaimer

Julian Vance is not a licensed physician or medical professional. All content published on RegenStep.com is thoroughly reviewed against cited primary sources and peer-reviewed literature for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider or doctor regarding any personal health condition or medical decisions, particularly concerning abnormal uterine bleeding, pelvic pain, fertility planning, or surgical options such as myomectomy and hysterectomy.

Julian Vance

Julian Vance is the writer and editor behind RegenStep, translating peer-reviewed longevity, metabolic, and gut-health research into practical, actionable guides. Julian is not a licensed physician; content is reviewed against cited primary sources and is for informational purposes only. Always consult a qualified healthcare provider for personal medical advice.